Most Popular
-
1
Reality show 'I Live Alone' disciplined for 'glorifying' alcohol consumption
-
2
Now is no time to add pressure on businesses: top executives
-
3
CJ CheilJedang to spur overseas growth with new Hungary, US plants
-
4
Blackpink's solo journeys: Complementary paths, not competition
-
5
Nationwide rail disruptions feared as union plans strike from Dec. 5
-
6
Nearly half of pines at Seoraksan face extinction due to global warming: study
-
7
Seoul to host winter festival from Dec. 13
-
8
N. Korea, Russia court softer image: From animal diplomacy to tourism
-
9
Smugglers caught disguising 230 tons of Chinese black beans as diesel exhaust fluid
-
10
[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
[DISCLOSURE] Macrogen (038290), a genome sequencing firm, announced on Sept. 21 that it has gained a patent for extracting fusion protein that encodes RET fusion protein which can be used as a diagnostic marker of cancer.
The patent includes primer pair of base sequence to detect KIF5B fusion protein and composite to inhibit activation of relevant fusion protein of lung cancer.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
The patent includes primer pair of base sequence to detect KIF5B fusion protein and composite to inhibit activation of relevant fusion protein of lung cancer.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
